Kirin Cashes Out of Amgen Drug Joint Venture for $780M Post author:Sam Post published:October 30, 2017 Post category:BioPharma Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen. Source: BioSpace You Might Also Like BOC Sciences's New Services-Antibody Drug Conjugates Service March 9, 2017 4 Biopharma Stocks a Billionaire Investor Just Bought February 16, 2017 SCYNEXIS, Inc. To Host A Conference Call To Discuss Lead Anti-Infective Candidate SCY-078 Data Presented At April 20, 2017
SCYNEXIS, Inc. To Host A Conference Call To Discuss Lead Anti-Infective Candidate SCY-078 Data Presented At April 20, 2017
